Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

Circulation

Volumn 105, Issue 4, 2002, Pages 446-451

  Niimura, Hideshi ^a,c   Patton, Kristen K ^a,b   McKenna, William J ^d   Soults, Johann ^a,g   Maron, Barry J ^e   Seidman, J G ^a   Seidman, Christine E ^a,f,h  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MILLENNIUM PHARMACEUTICALS INC   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aging; Cardiomyopathy; Genes; Hypertrophy

Indexed keywords

MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DNA SEQUENCE; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; ONSET AGE; PRIORITY JOURNAL; SARCOMERE; SEQUENCE ANALYSIS;

AGE OF ONSET; AMINO ACID SEQUENCE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; SARCOMERES; SEQUENCE ALIGNMENT; TROPONIN I;

EID: 0037192339     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0402.102990     Document Type: Article

References (32)

1. Functional obstruction of the left ventricle
2. Asymmetrical hypertrophy of the heart in young adults
3. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology and therapy
4. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
5. Hypertrophic cardiomyopathy
6. Quantitative analysis of the distribution of cardiac muscle cell disorganisation in the left ventricular wall of patients with hypertrophic cardiomyopathy
7. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study: Coronary artery risk development in (young) adults
8. Familial prevalence and genetic transmission of idiopathic hypertrophic cardiomyopathy
9. Patterns of inheritance in hypertrophic cardiomyopathy: Assessment by M-mode and two-dimensional echocardiography
10. Hypertrophic cardiomyopathy in the aged
11. Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients
12. Hypertrophic cardiomyopathy in the elderly
13. Recent advances in the molecular genetics of hypertrophic cardiomyopathy
14. Hypertrophic cardiomyopathy
15. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
16. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
17. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin binding protein-C gene
18. Mutations in the gene for cardiac myosin binding protein-C and late-onset familial hypertrophic cardiomyopathy
19. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy
20. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
21. Three-dimensional structure of myosin subfragment-1: A molecular motor
22. Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history
23. Hypertrophic subaortic stenosis in the aged
24. Idiopathic hypertrophic subaortic stenosis as observed in a large community hospital: Relation to age and history of hypertension
25. Idiopathic hypertrophic subaortic stenosis in the elderly
26. Natural history of hypertrophic cardiomyopathy in the elderly
27. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
28. Hypertrophic cardiomyopathy in the elderly: Distinctions from the young based on cardiac shape
29. Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life
30. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance
31. Molecular basis of cardiac performance
32. Myosin heavy chain gene expression in human heart failure